Accelerated hypofractionated radiotherapy schedules in breast cancer: A review of the current literature
AuthorKalogeridi, M. A.; Kelekis, N.; Kouvaris, J.; Platoni, K.; Kyrias, G.; Pectasides, D.; Kouloulias, V.
Lumpectomy followed by breast irradiation is an alternative to mastectomy for patients with early-stage breast cancer. The purpose of radiation treatment following lumpectomy is to minimize the risk of recurrent cancer in the treated breast with as little toxicity as possible so that good cosmesis and function are maintained. Conventional fractionation schedules for postlumpectomy radiotherapy give 50 Gy in 2 Gy daily fractions, often with an additional boost to the tumor bed, resulting in treatment being given over 5-7 weeks. Delivering postoperative radiotherapy in a shorter period of time, provided it is as effective as longer treatment regiments, could result in greater convenience for patients. Moreover, given the high incidence of breast cancer, the use of a shorter fractionation schedule would decrease waiting lists in busy radiotherapy departments. We searched the medline (pubmed) and we reviewed all the relevant publications. We concluded that the accelerated hypofractionated schedules are safe in terms of cosmesis and effective in terms of local control. © 2009 Bentham Science Publishers Ltd.
Showing items related by title, author, creator and subject.
Clinical validation of the LKB model and parameter sets for predicting radiation-induced pneumonitis from breast cancer radiotherapy Tsougos, I.; Mavroidis, P.; Theodorou, K.; Rajala, J.; Pitkänen, M. A.; Holli, K.; Ojala, A. T.; Hyödynmaa, S.; Järvenpää, R.; Lind, B. K.; Kappas, C. (2006)The choice of the appropriate model and parameter set in determining the relation between the incidence of radiation pneumonitis and dose distribution in the lung is of great importance, especially in the case of breast ...
High resolution computed tomography findings on the lung of early breast-cancer patients treated by postoperative breast irradiation with a hypofractionated radiotherapy schedule Plataniotis, G. A.; Theofanopoulou, M. E.; Sotiriadou, K.; Vlychou, M.; Fountoulis, G. A.; Fezoulidis, J. (2005)BACKGROUND: Hypofractionated breast radiotherapy (RT), although convenient for patients and health care systems, could have a negative impact on normal tissues such as lung. AIM: To evaluate radiation-induced lung toxicity ...
Radiotherapy of early breast cancer in scleroderma patients: Our experience with four cases and a short review of the literature Kyrgias, G.; Theodorou, K.; Zygogianni, A.; Tsanadis, K.; Zervoudis, S.; Tzitzikas, J.; Koukourakis, M. (2012)Purpose: Connective vascular diseases (CVD), including scleroderma, are reported to represent for some researchers a relative contraindication and for others absolute contraindication for radiotherapy. The purpose of our ...